LCZ Syrup contains Levocetirizine 2.5mg per 5ml, a second-generation antihistamine used primarily for the relief of allergic symptoms. Levocetirizine is the active enantiomer of cetirizine, exhibiting selective peripheral H1 receptor antagonism, which effectively reduces histamine-mediated allergic responses without significant sedation. LCZ Syrup is indicated for the treatment of allergic rhinitis, including seasonal and perennial forms, as well as chronic idiopathic urticaria, providing symptomatic relief from sneezing, nasal congestion, rhinorrhea, itching, and hives. The syrup formulation allows for easy administration in pediatric patients or those who have difficulty swallowing tablets. LCZ Syrup demonstrates a rapid onset of action, typically within one hour, and maintains efficacy for up to 24 hours, permitting once-daily dosing. It is generally well tolerated, with a low incidence of adverse effects such as drowsiness, dry mouth, and fatigue. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. LCZ Syrup should be used under medical supervision, especially in children, pregnant or lactating women. It is contraindicated in patients with known hypersensitivity to levocetirizine or any of the syrup’s excipients. Proper adherence to prescribed dosage ensures optimal therapeutic outcomes in managing allergic conditions.